DOES GONADOTROPIN SUPPRESSION RESULT IN FOLLICULAR DEVELOPMENT IN PREMATURE OVARIAN FAILURE

被引：9

作者：

BUCKLER, HM

HEALY, DL

BURGER, HG

机构：

[1] Prince Henry's Institute of Medical Research, Monash Medical Centre, Melbourne

来源：

GYNECOLOGICAL ENDOCRINOLOGY | 1993年 / 7卷 / 02期

关键词：

FOLLICULAR DEVELOPMENT; GONADOTROPIN SUPPRESSION; PREMATURE OVARIAN FAILURE;

D O I：

10.3109/09513599309152491

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

It was hypothesized that premature ovarian failure is a self-perpetuating problem and that suppression of the endogenously raised gonadotropin levels may allow synchronization of follicular growth, so that when the suppression is removed, follicular development may be stimulated by the rapid rise in follicle stimulating hormone (FSH) levels. Microgynon(R) (ethinylestradiol, 30 mug and levonorgestrel, 150 mug) was administered to eight women with premature ovarian failure for 12 weeks. Serum samples were collected weekly for radioimmunoassay of FSH, luteinizing hormone (LH), estradiol, progesterone and inhibin. On stopping Microgynon, ovarian ultrasonography was carried out, in addition to blood sampling, to monitor any follicular growth. Both FSH and LH levels declined to the normal follicular-phase range after 5 weeks of Microgynon treatment (mean +/- SD: FSH, 6.5 +/- 1.2 IU/l; LH, 8.9 +/- 1.6 IU/l). Both hormone levels rose rapidly after stopping treatment and were above the normal follicular-phase range by the 1st week. FSH reached pretreatment levels by 3 weeks, but LH did not reach the previously high levels until 7 weeks after stopping Microgynon administration. Estradiol and immunoreactive inhibin levels in serum were undetectable throughout the study. No follicular growth was seen on ultrasound scanning. Therefore, gonadotropin suppression in premature ovarian failure does not result in a resumption of follicular activity.

引用

页码：123 / 128

页数：6

共 23 条

[1]

Rebar R.W., Erickson G.F., Yen S.S.C., Idiopathic premature ovarian failure: clinical and endocrine characteristics, Fertil. Steril., 37, pp. 35-41, (1982)

[2]

Goldberg R.L., Grodin J.M., Rodbard D., Ross G.T., Gonadotrophins in women with amenorrhoea, Am. J. Obstet. Gynecol., 116, pp. 1003-1012, (1973)

[3]

Shapiro A.G., Rubin A., Spontaneous pregnancy in association with hypergonadotrophic ovarian failure, Fertil. Steril, 28, pp. 500-501, (1977)

[4]

Wright C.S.W., Jacobs H.S., Spontaneous pregnancy in a patient with hypergonadotrophic ovarian failure, Br. J. Obstet. Gynaecol., 86, pp. 389-390, (1979)

[5]

O'Herlihy C., Pepperell R.J., Evans J.H., The significance of FSH elevation in young women with disorders of ovulation, Br. Med. J., 281, pp. 1447-1450, (1980)

[6]

Polansky S., De Papp E., Pregnancy associated with hypergonadotrophic hypogonadism, Obstet. Gynecol., 47, pp. 47-51, (1976)

[7]

Shangold M.M., Turksoy R.N., Bashford R.A., Hammond C.B., Pregnancy following the insensitive ovary syndrome, Fertil. Steril., 28, pp. 1179-1181, (1977)

[8]

Szlachter B.N., Nachtigall L.E., Epstein J., Young B.K., Weiss G., Premature menopause: a reversible entity?, Obstet. Gynecol., 54, pp. 396-398, (1979)

[9]

Ylostalo P., Huhtaniemi I., Reinila M., Induction of ovulation with low-dose estrogen-progestin therapy in amenorrheic patients, Int. J. Fertil., 27, pp. 153-155, (1982)

[10]

Alper M.A., Jolly E.E., Garner P.R., Pregnancies after premature ovarian failure, Obstet. Gynecol., 67, pp. 59-69, (1986)

← 1 2 3 →